Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | CFTR | P13569 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL465737 | 0.92 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL31634613 | 0.92 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL14828745 | 0.92 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL28957307 | 0.92 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL27475798 | 0.90 | ALDH1A1 (0.56) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL505249 | 0.90 | ALDH1A1 (0.71) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL31589985 | 0.90 | ALDH1A1 (0.71) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| Ether SCHEMBL5903649 | 0.89 | ALDH1A1 (0.55) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL29601872 | 0.88 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CFTRTSHRLMNA | |
| SCHEMBL31038441 | 0.88 | LMNA (0.66) | ALDH1A1HSD17B10CFTRTSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104549164-B | Micropore metal organic framework materials adsorbed for methane and acetylene and store and preparation method thereof | 浙江大学 | 2016-08-24 | — | — | CN | claimed |
| EP-3166981-B1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| CN-119528992-A | Ester-substituted palladium complex and preparation method and application thereof | 链行走新材料科技(广州)有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119463134-A | Application of ester-substituted palladium complex in preparation of long ether chain thiophene copolymer | 链行走新材料科技(广州)有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-115279730-B | 2, 5-Or 2, 6-disubstituted hydroquinone derivatives having at least one carboxyl, sulfo or amido group, useful as medicaments | OM药物公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-4118069-B1 | PARA-HYDROQUINONE DERIVATIVES AS VEGF, TNF AND/OR IL INHIBITORS FOR THE TREATMENT OF NEUROINFLAMMATORY DISEASES | OM PHARMA SA (CH) | 2024-10-23 | — | — | EP | disclosed |
| US-12110307-B2 | Self-immolative systems | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2024-10-08 | — | — | US | disclosed |
| EP-3459975-B1 | POLYMERIC ACID CATALYSTS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2024-10-02 | — | — | EP | disclosed |
| US-20230150951-A1 | 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS | OM PHARMA SA (CH) | 2023-05-18 | — | — | US | disclosed |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-RE33635-E | Enzymatic assay method | TOYO JOZO KABUSHIKI KAISHA (JP) | 1991-07-09 | — | — | US | disclosed |
| US-4931502-A | Ductile, blow moldable composition containing a styrene-maleimide copolymer bearing pendant carboxyl or hydroxyl groups | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1990-06-05 | — | — | US | disclosed |
| EP-0357459-A2 | Moldable styrene-maleic anhydride/polybutylene terephthalate composition | ARCO Chemical Technology, L.P. (US) | 1990-03-07 | — | — | EP | disclosed |
| US-4891405-A | STYRENE-MALEIMIDE COPOLYMER HAVING PENDANT CARBOXYL OR GROUPS | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1990-01-02 | — | — | US | disclosed |
| US-4711898-A | 4-quinolone derivatives having anti-inflammatory, anti-allergic, antitussive, expectorant and antithrombotic activity | NIPPON SHINYAKU CO., LTD. (JP) | 1987-12-08 | — | — | US | disclosed |
| US-4681841-A | CONSUMING OXYGEN OR GENERATING A PIGMENT; MEASUREMENT BY AN OXYGEN ELECTRODE OR COLORIMETRIC ASSAY | TOYO JOZO KABUSHIKI KAISHA (JP) | 1987-07-21 | — | — | US | disclosed |
| EP-0104959-B1 | 4-QUINOLONE DERIVATIVES | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1987-01-21 | — | — | EP | disclosed |
| EP-0169167-A2 | Process for dyeing high-molecular organic materials, and metal complexes | CIBA-GEIGY AG (CH) | 1986-01-22 | — | — | EP | disclosed |
| EP-0104959-A1 | 4-Quinolone derivatives | NIPPON SHINYAKU COMPANY, LIMITED (JP) | 1984-04-04 | — | — | EP | disclosed |
| US-4302241-A | N-(PYRIMIDIN-2-YL-AMINOCARBONYL) ARYL SULFONAMIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150951-A1 | 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS | HRH4, NCOA4, HRH3 | ALDH1A1 3025/4885HSD17B10 115/4885CFTR 1948/4885 |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | OSTC, FUT5, FUT6 | ALDH1A1 2641/4885HSD17B10 1297/4885CFTR 3407/4885 |
| US-12110307-B2 | Self-immolative systems | MCL1, BCL3, BAP1 | ALDH1A1 3669/4885HSD17B10 4342/4885CFTR 1622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.